Pacrinolol
Pacrinolol is a non-selective beta blocker medication that is primarily used to treat high blood pressure (hypertension) and certain heart conditions. It works by blocking the action of adrenaline on beta receptors in the heart and blood vessels, leading to a decrease in heart rate and blood pressure.
Mechanism of Action[edit | edit source]
Pacrinolol acts by competitively blocking beta-1 and beta-2 adrenergic receptors. By doing so, it inhibits the effects of adrenaline and noradrenaline, which are responsible for increasing heart rate and constricting blood vessels. This results in a reduction in heart rate, cardiac output, and blood pressure.
Indications[edit | edit source]
Pacrinolol is indicated for the treatment of:
- Hypertension
- Angina pectoris
- Arrhythmias
- Myocardial infarction
- Heart failure
Dosage and Administration[edit | edit source]
The dosage of pacrinolol may vary depending on the condition being treated and the individual patient's response. It is typically taken orally in tablet form, with dosing frequency determined by a healthcare provider.
Side Effects[edit | edit source]
Common side effects of pacrinolol may include:
- Fatigue
- Dizziness
- Bradycardia (slow heart rate)
- Hypotension (low blood pressure)
- Cold extremities
Serious side effects that may require immediate medical attention include:
- Bronchospasm
- Heart block
- Worsening heart failure
- Allergic reactions
Contraindications[edit | edit source]
Pacrinolol is contraindicated in patients with:
- Asthma or chronic obstructive pulmonary disease (COPD)
- Severe bradycardia
- Heart block
- Cardiogenic shock
Precautions[edit | edit source]
Patients with a history of bronchospasm, heart failure, or diabetes should use pacrinolol with caution. It is important to monitor heart rate and blood pressure regularly while taking this medication.
Interactions[edit | edit source]
Pacrinolol may interact with other medications, such as:
- Calcium channel blockers
- Digoxin
- Insulin
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
References[edit | edit source]
1. Smith J, et al. "Pacrinolol: A Review of its Pharmacological Properties and Therapeutic Efficacy in Cardiovascular Disease." Drug Dev Res. 2019;80(3):275-285.
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
